CASE HISTORY
A 22-year-old woman was admitted to the emergency department with productive cough, fevers and shortness of breath, worsening over four weeks. This was her third presentation to the emergency department in four weeks with flu-like symptoms, the two prior presentations being for mild symptoms only. She was taking a course of oral amoxycillin (Augmentin, GlaxoSmithKline), was on no other regular medications and had no known drug allergies. Her past medical history was unremarkable but she was noted to be morbidly obese with a body mass index on admission of 50.1. She had no recent history of travel and no contact with tuberculosis but other members of her family were unwell with flu-like symptoms at the time, although none had required hospital admission.
She was initially admitted to the medical ward with fever (temperature 38.9°C), sinus tachycardia (heart rate 110 to 130 /min) and tachypnoea (respiratory rate 25 to 30 /min). Arterial blood gas analysis showed hypoxaemia (PO 2 70 mmHg, SpO 2 94%). Her physiological parameters returned towards normal limits with intravenous fluid and oxygen administration and she was treated with intravenous cefuroxime and clarithromycin.
Seventy-two hours after her admission she was transferred to the intensive care unit (ICU) with increasing respiratory distress, worsening hypoxia and hypotension. Following assessment, her trachea was intubated and she was mechanically ventilated. There was no evidence of other organ failure during her course in the ICU and standard biochemistry and haematology tests were all within normal ranges apart from an elevated C-reactive protein (peak 240 mg/l). The patient remained febrile for 12 days with temperatures ranging between 38 to 41°C.
Oseltamivir, 75 mg bd via nasogastic tube, was commenced on the day of intubation and continued for nine days. Noradrenaline infusion was started for hypotension and continued for 10 days. Antibiotic therapy was continued on ICU admission with clarithromycin (10 days) and cefepime (three days); vancomycin was added on day seven for four days.
On day two of ICU admission, influenza virus type A RNA and AH1N1 (swine influenza) RNA were detected by real time reverse-transcriptase polymerase chain reaction (Influenza A matrix gene) 1 . Multiple blood cultures, tracheal aspirates and one bronchoalveolar lavage failed to isolate any other organism.
Following intubation in ICU, ventilation was intitiated using a Hamilton Galileo ventilator (Hamilton, Bonaduz, Switzerland). We utilised the acute respiratory distress syndrome net 
SUMMARY
The recently emerged novel influenza A H1N1 virus continues to spread globally. The use of oseltamivir for treatment and prophylaxis of infection is recommended and its use has climbed steeply although there is little data available on its benefit in critically unwell patients with H1N1 influenza. A rare side-effect of oseltamivir treatment reported in post-marketing surveillance is tongue and lip swelling/angioedema. This case report describes the management of a critically ill ventilated patient with severe acute respiratory distress syndrome who developed clinically significant tongue and lip swelling during treatment with oseltamivir. settings for ventilation. Lung compliance was low and was further reduced in the first 24 hours necessitating reduction in tidal volumes to as low as 3 ml/kg at times to maintain plateau pressures under 30 cmH 2 O. Oxygenation was compromised with even the smallest of movements or suctioning. Alveolar recruitment was gained by sequential increase, then slow reduction in positive endexpiratory pressure (PEEP) as described by Tuxen (D. Tuxen, personal communication).
Prone positioning was utilised for six hours on day three, with no improvement in compliance and transiently reduced oxygenation secondary to movement. Central venous pressure was maintained at 12 to 16 cmH 2 O with frusemide and mannitol. By day 10, ventilation had steadily improved and recruitment manoeuvres were no longer required.
The patient began to develop mild tongue swelling on day three in ICU. This swelling increased significantly over the next six days and moderate lip swelling was also noted (Figure 1 ). As the size and firmness of the tongue increased it became impossible to retract it into the mouth and the upper and lower incisors, along with the endotracheal tube (ETT), caused pressure and ulceration, impairing venous drainage. Care was provided to keep the tongue moist and dental blocks were used to relieve the pressure of the teeth and ETT. Oseltamivir was ceased after nine days of treatment and the swelling began to reduce over the next few days. The potential for a difficult intubation and airway compromise, should the ETT be displaced, was great. The ETT was carefully secured and tracheostomy was delayed until the swelling had reduced. A dilatational percutaneous tracheostomy was performed on day 16, by which time the swelling had already reduced significantly.
A hollow bougie was passed through the ETT to maintain access to the trachea throughout the procedure. Laryngoscopy performed at the time confirmed that endotracheal intubation would have been possible. The patient continued to improve in intensive care with a prolonged period of ventilation, but oxygen and pressure support requirements were slow to reduce. Decannulation of the trachea occurred at day 31, with discharge from ICU on day 32. She continued to improve and was discharged from hospital on day 40.
DISCUSSION
Significant airway compromise as a result of oedema of the tongue and lips complicated the management of this patient. While it is difficult to determine the exact cause of tongue and lip swelling in this patient, the onset and regression of symptoms were closely related to the course of oseltamivir. The oseltamivir data sheet describes this as a rare side-effect reported during postmarketing surveillance 3 . We have been unable to find any other case reports documenting tongue swelling or airway compromise related to oseltamivir (Medline and Embase searches), or from novel H1N1 infections. Multiple studies have shown benefit from oseltamivir in seasonal influenza, when administered early, with a reduction in both duration of symptoms and secondary infection in otherwise healthy adults 4, 5 . The use of oseltamivir and its role in critically unwell patients has yet to be established and a randomised controlled trial would be difficult to conduct. Other possible contributors to tongue swelling include positioning, trauma, immobility, high PEEP and fluid overload, and these are discussed below.
The swelling was noted early on but was prominent immediately upon returning to supine after six hours of prone positioning. The swelling did not reduce after returning to supine and in fact increased over the next few days. The patient was nursed in a 30 to 45 degree head-up position while supine, and was in reverse Trendelenburg position while prone. Positioning is thought unlikely to be a major contributor to the oedema.
Localised trauma and obstruction was also considered. There were some minor incisor marks on the underside of the tongue after turning supine with some localised damage to the mucosa, though this was minor. There was evidence of ulceration to the tongue as a result of endotracheal tube and teeth pressure but this occurred once the tongue was already swollen. Though this may have contributed to the tongue swelling, it does not explain the associated lip swelling.
The patient received deep sedation and neuromuscular blockade during the first few days to ensure ventilator synchrony and to improve oxygenation, reduce inflammatory mediators and to prevent damage induced by spontaneous high tidal volume breaths [6] [7] [8] . The effect of this strategy and the sensitivity of oxygenation to any sort of intervention necessitated paralysis. It is possible that immobility and inactivity of the tongue may have contributed to this swelling. However a great many patients receive heavy sedation and neuromuscular blockade during their intensive care stay and tongue swelling is not described even as an infrequent complication.
It is possible that high levels of PEEP used in this patient contributed to the swelling via impaired venous drainage, though it would be unusual to find such significant tongue and lip swelling in isolation as has occurred in this case.
Fluid overload is a possible but unlikely contributing factor. During the period when tongue swelling was prominent, the patient was managed in a relatively hypovolaemic or euvolaemic state with a central venous pressure of 12 to 16 cmH 2 O (in the setting of PEEP 10 to 15 cmH 2 O) supported by moderate levels of pressor agents. Active diuresis with mannitol and frusemide was undertaken in an attempt to limit pulmonary oedema-induced hypoxaemia.
No other medication used had a propensity to cause selective tongue and lip swelling, and we were unable to establish any other trigger for the swelling. Tongue and lip swelling from the use of oseltamivir is an uncommon but potentially hazardous adverse event in the critically ill patient with swine flu. This possible reaction to oseltamivir has been reported to the Center for Adverse Reactions Monitoring at University of Otago Medical School.
